Skip to content
Search for:
ABOUT
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PIPELINE
ENVAFOLIMAB (KN035)
TRC102
YH001
CLINICAL TRIALS
EXPANDED ACCESS POLICY
PARTNERS
NEWS
PRESS RELEASES
VIDEO PRESENTATIONS
INVESTORS
PRESS RELEASES
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
FINANCIALS & FILINGS
SEC FILINGS
ANNUAL REPORTS & PROXIES
QUARTERLY REPORTS
STOCK INFORMATION
HISTORICAL PRICE LOOKUP
INVESTMENT CALCULATOR
INVESTOR FAQ
CONTACT
CONTACT
CAREERS
COMMUNITY
UNNECESSARY EXPENSE
Classic Home
admin
2021-09-03T12:02:54+00:00
OUR GOAL IS TO BE A LEADER IN THE DEVELOPMENT OF TARGETED THERAPIES FOR PATIENTS WITH CANCER AND OTHER DISEASES OF HIGH UNMET NEED
Page load link
Go to Top